{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:41:45Z","timestamp":1793270505489,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Severe combined immunodeficiency (SCID) encompasses a range of inherited disorders that lead to a profound deterioration of the immune system. Among the pivotal genes associated with SCID, <jats:italic>RAG1<\/jats:italic> and <jats:italic>IL2RG<\/jats:italic> play crucial roles. <jats:italic>IL2RG<\/jats:italic> is essential for the development, differentiation, and functioning of T, B, and NK cells, while <jats:italic>RAG1<\/jats:italic> critically contributes to adaptive immunity by facilitating V(D)J recombination during the maturation of lymphocytes. Animal models carrying mutations in these genes exhibit notable deficiencies in their immune systems. Non-human primates (NHPs) are exceptionally well-suited models for biomedical research due to their genetic and physiological similarities to humans. Cytosine base editors (CBEs) serve as powerful tools for precisely and effectively modifying single-base mutations in the genome. Their successful implementation has been demonstrated in human cells, mice, and crop species. This study outlines the creation of an immunodeficient monkey model by deactivating both the <jats:italic>IL2RG<\/jats:italic> and <jats:italic>RAG1<\/jats:italic> genes using the CBE4max system. The base-edited monkeys exhibited a severely compromised immune system characterized by lymphopenia, atrophy of lymphoid organs, and a deficiency of mature T cells. Furthermore, these base-edited monkeys were capable of hosting and supporting the growth of human breast cancer cells, leading to tumor formation. In summary, we have successfully developed an immunodeficient monkey model with the ability to foster tumor growth using the CBE4max system. These immunodeficiency monkeys show tremendous potential as valuable tools for advancing biomedical and translational research.<\/jats:p>","DOI":"10.1038\/s41392-023-01544-y","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:02:22Z","timestamp":1693785742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Generation of inactivated IL2RG and RAG1 monkeys with severe combined immunodeficiency using base editing"],"prefix":"10.1038","volume":"8","author":[{"given":"Xiao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bofeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weien","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuchi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-1570","authenticated-orcid":false,"given":"Sen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"1544_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/nyas.12849","volume":"1356","author":"E Cirillo","year":"2015","unstructured":"Cirillo, E. et al. Severe combined immunodeficiency\u2013an update. Ann. N. Y. Acad. Sci. 1356, 90\u2013106 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1544_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.0105-2896.2005.00223.x","volume":"203","author":"A Fischer","year":"2005","unstructured":"Fischer, A. et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol. Rev. 203, 98\u2013109 (2005).","journal-title":"Immunol. Rev."},{"key":"1544_CR3","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1056\/NEJMoa073966","volume":"19","author":"C Schuetz","year":"2008","unstructured":"Schuetz, C. et al. An immunodeficiency disease with RAG mutations and granulomas. N. Engl. J. Med. 19, 2030\u20132038 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1544_CR4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s10875-014-0088-2","volume":"34","author":"SA Ban","year":"2014","unstructured":"Ban, S. A. et al. Combined immunodeficiency evolving into predominant CD4+ lymphopenia caused by somatic chimerism in JAK3. J. Clin. Immunol. 34, 941\u2013953 (2014).","journal-title":"J. Clin. Immunol."},{"key":"1544_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jaci.2010.09.036","volume":"127","author":"MA Slatter","year":"2011","unstructured":"Slatter, M. A. et al. Polymorphous lymphoproliferative disorder with Hodgkin-like features in common gamma-chain-deficient severe combined immunodeficiency. J. Allergy Clin. Immunol. 127, 533\u2013535 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1544_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13223-018-0317-y","volume":"15","author":"CK Lim","year":"2019","unstructured":"Lim, C. K., Abolhassani, H., Appelberg, S. K., Sundin, M. & Hammarstrom, L. IL2RG hypomorphic mutation: identification of a novel pathogenic mutation in exon 8 and a review of the literature. Allergy Asthma Clin. Immunol. 15, 2 (2019).","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"1544_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.stem.2012.04.021","volume":"10","author":"S Suzuki","year":"2012","unstructured":"Suzuki, S. et al. Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell 10, 753\u2013758 (2012).","journal-title":"Cell Stem Cell"},{"key":"1544_CR8","doi-asserted-by":"publisher","first-page":"109824","DOI":"10.1016\/j.celrep.2021.109824","volume":"37","author":"T Gan","year":"2021","unstructured":"Gan, T., Wang, Y., Liu, Y., Schatz, D. G. & Hu, J. RAG2 abolishes RAG1 aggregation to facilitate V(D)J recombination. Cell Rep. 37, 109824 (2021).","journal-title":"Cell Rep."},{"key":"1544_CR9","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1128\/MCB.22.10.3460-3473.2002","volume":"22","author":"LE Huye","year":"2002","unstructured":"Huye, L. E., Purugganan, M. M., Jiang, M. M. & Roth, D. B. Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase. Mol. Cell Biol. 22, 3460\u20133473 (2002).","journal-title":"Mol. Cell Biol."},{"key":"1544_CR10","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1182\/blood-2002-01-0187","volume":"101","author":"JG Noordzij","year":"2003","unstructured":"Noordzij, J. G. et al. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow. Blood 101, 1446\u20131452 (2003).","journal-title":"Blood"},{"key":"1544_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","volume":"68","author":"P Mombaerts","year":"1992","unstructured":"Mombaerts, P. et al. RAG-1 deficient mice have no mature B and T lymphocyte. Cell 68, 869\u2013877 (1992).","journal-title":"Cell"},{"key":"1544_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1096\/fj.201800102RR","volume":"33","author":"D He","year":"2019","unstructured":"He, D. et al. A novel immunodeficient rat model supports human lung cancer xenografts. FASEB J. 33, 140\u2013150 (2019).","journal-title":"FASEB J."},{"key":"1544_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2020.00100","volume":"11","author":"AN Boettcher","year":"2020","unstructured":"Boettcher, A. N. et al. Novel engraftment and T cell differentiation of human hematopoietic cells in ART(-\/-)IL2RG(-\/Y) SCID pigs. Front. Immunol. 11, 100 (2020).","journal-title":"Front. Immunol."},{"key":"1544_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ajp.22281","volume":"76","author":"KA Phillips","year":"2014","unstructured":"Phillips, K. A. et al. Why primate models matter. Am. J. Primatol. 76, 801\u2013827 (2014).","journal-title":"Am. J. Primatol."},{"key":"1544_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","volume":"24","author":"RJ Ihry","year":"2018","unstructured":"Ihry, R. J. et al. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat. Med. 24, 939\u2013946 (2018).","journal-title":"Nat. Med."},{"key":"1544_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.celrep.2015.04.007","volume":"11","author":"FT Merkle","year":"2015","unstructured":"Merkle, F. T. et al. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Cell Rep. 11, 875\u2013883 (2015).","journal-title":"Cell Rep."},{"key":"1544_CR17","doi-asserted-by":"publisher","first-page":"e04766","DOI":"10.7554\/eLife.04766","volume":"3","author":"S Lin","year":"2014","unstructured":"Lin, S., Staahl, B. T., Alla, R. K. & Doudna, J. A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery. Elife 3, e04766 (2014).","journal-title":"Elife"},{"key":"1544_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1544_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01518-8","volume":"21","author":"SW Wang","year":"2022","unstructured":"Wang, S. W. et al. Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer. Mol. Cancer 21, 57 (2022).","journal-title":"Mol. Cancer"},{"key":"1544_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2016.10.044","volume":"168","author":"AC Komor","year":"2017","unstructured":"Komor, A. C., Badran, A. H. & Liu, D. R. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell 168, 20\u201336 (2017).","journal-title":"Cell"},{"key":"1544_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nbt.3816","volume":"35","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. Highly efficient RNA-guided base editing in mouse embryos. Nat. Biotechnol. 35, 435\u2013437 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1544_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nbt.3833","volume":"35","author":"Z Shimatani","year":"2017","unstructured":"Shimatani, Z. et al. Targeted base editing in rice and tomato using a CRISPR-Cas9 cytidine deaminase fusion. Nat. Biotechnol. 35, 441\u2013443 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1544_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843\u2013846 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1544_CR24","doi-asserted-by":"publisher","first-page":"102174","DOI":"10.1016\/j.psj.2022.102174","volume":"101","author":"T Xu","year":"2022","unstructured":"Xu, T. et al. Optimization of the base editor BE4max in chicken somatic cells. Poult. Sci. 101, 102174 (2022).","journal-title":"Poult. Sci."},{"key":"1544_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep42081","volume":"7","author":"Z Tu","year":"2017","unstructured":"Tu, Z. et al. Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos. Sci. Rep. 7, 42081 (2017).","journal-title":"Sci. Rep."},{"key":"1544_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-019-0142-y","volume":"29","author":"W Yang","year":"2019","unstructured":"Yang, W. et al. CRISPR\/Cas9-mediated PINK1 deletion leads to neurodegeneration in rhesus monkeys. Cell Res. 29, 334\u2013336 (2019).","journal-title":"Cell Res."},{"key":"1544_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.5483\/BMBRep.2019.52.11.267","volume":"52","author":"MA Iqbal","year":"2019","unstructured":"Iqbal, M. A., Hong, K., Kim, J. H. & Choi, Y. Severe combined immunodeficiency pig as an emerging animal model for human diseases and regenerative medicines. BMB Rep. 52, 625\u2013634 (2019).","journal-title":"BMB Rep."},{"key":"1544_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35886-6","volume":"14","author":"J Tao","year":"2023","unstructured":"Tao, J., Bauer, D. E. & Chiarle, R. Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing. Nat. Commun. 14, 212 (2023).","journal-title":"Nat. Commun."},{"key":"1544_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10421-8","volume":"10","author":"J Xie","year":"2019","unstructured":"Xie, J. et al. Efficient base editing for multiple genes and loci in pigs using base editors. Nat. Commun. 10, 2852 (2019).","journal-title":"Nat. Commun."},{"key":"1544_CR30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.cell.2014.01.027","volume":"156","author":"Y Niu","year":"2014","unstructured":"Niu, Y. et al. Generation of gene-modified cynomolgus monkey via Cas9\/RNA-mediated gene targeting in one-cell embryos. Cell 156, 836\u2013843 (2014).","journal-title":"Cell"},{"key":"1544_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","volume":"12","author":"NC Walsh","year":"2017","unstructured":"Walsh, N. C. et al. Humanized mouse models of clinical disease. Annu. Rev. Pathol. 12, 187\u2013215 (2017).","journal-title":"Annu. Rev. Pathol."},{"key":"1544_CR32","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/TP.0000000000002251","volume":"102","author":"S Menoret","year":"2018","unstructured":"Menoret, S. et al. Generation of immunodeficient rats with Rag1 and Il2rg gene deletions and human tissue grafting models. Transplantation 102, 1271\u20131278 (2018).","journal-title":"Transplantation"},{"key":"1544_CR33","volume":"3","author":"ZQ Yan Q","year":"2014","unstructured":"Yan Q, Z. Q. et al. Generation of multigene knockout rabbits using the Cas9gRNA system. Cell Regen. 3, 12 (2014).","journal-title":"Cell Regen."},{"key":"1544_CR34","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/emboj.2013.86","volume":"32","author":"T Cavlar","year":"2013","unstructured":"Cavlar, T., Deimling, T., Ablasser, A., Hopfner, K. P. & Hornung, V. Species-specific detection of the antiviral small-molecule compound CMA by STING. EMBO J. 32, 1440\u20131450 (2013).","journal-title":"EMBO J."},{"key":"1544_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep18035","volume":"5","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Rat and human STINGs profile similarly towards anticancer\/antiviral compounds. Sci. Rep. 5, 18035 (2015).","journal-title":"Sci. Rep."},{"key":"1544_CR36","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1158\/1078-0432.CCR-08-2502","volume":"15","author":"BM Carreno","year":"2009","unstructured":"Carreno, B. M. et al. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases. Clin. Cancer Res. 15, 3277\u20133286 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1544_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3727\/000000005783982837","volume":"14","author":"SD Silva-Barbosa","year":"2005","unstructured":"Silva-Barbosa, S. D., Butler-Browne, G. S., Di Santo, J. P. & Mouly, V. Comparative analysis of genetically engineered immunodeficient mouse strains as recipients for human myoblast transplantation. Cell Transplant. 14, 457\u2013467 (2005).","journal-title":"Cell Transplant."},{"key":"1544_CR38","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1054\/bjoc.1999.0991","volume":"82","author":"MK Oehler","year":"2000","unstructured":"Oehler, M. K. & Bicknell, R. The promise of anti-angiogenic cancer therapy. Br. J. Cancer 82, 749\u2013752 (2000).","journal-title":"Br. J. Cancer"},{"key":"1544_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/cr.2018.9","volume":"28","author":"X Yao","year":"2018","unstructured":"Yao, X. et al. Generation of knock-in cynomolgus monkey via CRISPR\/Cas9 editing. Cell Res. 28, 379\u2013382 (2018).","journal-title":"Cell Res."},{"key":"1544_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/cr.2015.112","volume":"26","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Generation of macaques with sperm derived from juvenile monkey testicular xenografts. Cell Res. 26, 139\u2013142 (2016).","journal-title":"Cell Res."},{"key":"1544_CR41","first-page":"881","volume":"172","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. Cloning of macaque monkeys by somatic. Cell Nucl. Transf. Cell 172, 881\u2013887.e887 (2018).","journal-title":"Cell Nucl. Transf. Cell"},{"key":"1544_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/nsr\/nwz003","volume":"6","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. Cloning of a gene-edited macaque monkey by somatic cell nuclear transfer. Natl Sci. Rev. 6, 101\u2013108 (2019).","journal-title":"Natl Sci. Rev."},{"key":"1544_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"1544_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1544_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"1544_CR46","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J. S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"1544_CR47","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01544-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01544-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T07:02:16Z","timestamp":1700377336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01544-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01544-y","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}